Yoon JH, Baek SJ. Molecular targets of dietary polyphenols with anti-inflammatory
properties. Yonsei Med J. 2005;46(5):585-96.
Herrick AL, Worthington H, Rieley F, et al. Dietary intake of micronutrient antioxidants
in relation to blood levels in patients with systemic sclerosis. J Rheumatol. 1996;23(4):650-653.
Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence.
Nat Rev Drug Discov. 2006;5(6):493-506.
Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am
Coll Nutr. 2002;21(6):495-505.
Wang HK. The therapeutic potential of flavonoids. Expert Opin Investig Drugs. 2000;9(9):2103-19.
Hale LP, Greer PK, Trinh CT, James CL. Proteinase activity and stability of natural
bromelain preparations. Int Immunopharmacol. 2005;5(4):783-93.
Rheumatoid Factor.
Rostaing L, Modesto A, Cisterne JM, Izopet J, Oksman F, Duffaut M, Abbal M, Durand
D (1998). "Serological markers of autoimmunity in renal transplant patients with
chronic hepatitis C". American journal of nephrology 18 (1): 50–56. Patient UK -Internet Page.
Scleroderma.
Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier;
2007.Varga J, Denton CP. Systemic sclerosis and the scleroderma-spectrum disorders.
In: Firestein GS, Budd RC, Harris ED Jr., et al., eds. Kelley's Textbook of Rheumatology.
8th ed. Philadelphia, Pa: Saunders Elsevier; 2008:chap 77.
Clouse RE, Diamant NE. Esophageal motor and sensory function and motor disorders
of the esophagus. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's
Gastrointestinal and Liver Disease. 8th ed. Philadelphia, Pa: Saunders Elsevier;
2006:chap 41.
Maeda M, Kachi H, Ichihashi N et al. The effect of electrical acupuncture-stimulation
therapy using thermography and plasma endothelin (ET-1) levels in patients with progressive
system sclerosis (PSS). J Dermatol Sci. 1998;17(2):151-155.
Wollina U, Abdel-Naser MB, Mani R. A review of the microcirculation in skin in patients
with chronic venous insufficiency: the problem and the evidence available for therapeutic
options. Int J Low Extrem Wounds. 2006;5(3):169-80.
Herrick AL. Advances in palliative care for the patient with scleroderma. Curr Opin
Rheumatol. 1996;8(6):555-60.
Hunnicutt SE, Grady J, McNearney TA. Complementary and alternative medicine use was
associated with higher perceived physical and mental functioning in early systemic
sclerosis. Explore (NY). 2008 Jul-Aug;4(4):259-63.
Casale R et al Systemic sclerosis (scleroderma): an integrated challenge in rehabilitation.
Arch Phys Med Rehab. 1997;78(7):767-73.
Kartnig T. Clinical applications of Centella asiatica (L.) Urb. Herbs Spices Med
Plants. 1988;3:145–173.
third party websites are not under the control of proventus.org.uk and therefore
we are not responsible for their content, nor should their inclusion on our website
be construed as an endorsement of their site.
If you would like us to include a link to your website. Contact us
Sometimes web sites are hacked without our knowledge.
Please report any abusive or misleading third party websites to Proventus